Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Surrey M Walton

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Journal of Medical Systems|June 3, 2004
The pharmacist shortage and medication errors: issues and evidenceSurrey M Walton
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2015
Cost-effectiveness of the 70-gene signature versus adjuvant! Online and systematic chemotherapy for risk stratification of patients with node-negative breast cancer: does accuracy matter?Catherine Rahilly-Tierney, Surrey M Walton
Healthcare Financial Management : Journal of the Healthcare Financial Management Association|October 17, 2003
Expenditures for prescription drugs: too much or not enough?Glen T Schumock, Surrey M Walton
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2005
Discussion of "Comparison of clinical and cost-effectiveness of 3 intervention strategies for HIV wasting"Hind T Hatoum, Surrey M Walton
Pharmacy (Basel, Switzerland)|July 5, 2018
Is It a Good Time to Be a Pharmacist in the US?Surrey M Walton, Henri R Manasse
Pharmacoeconomics|October 2, 2014
Should off-label drugs be included as comparators in pharmacoeconomic studies?Surrey M Walton, Glen T Schumock
Vaccine|February 20, 2016
HPV vaccine: Less is moreRachel Caskey, Steven Andes, Surrey M Walton
Journal of Allied Health|September 11, 2017
Considering Recent Trends in Healthcare Labor Markets in Educational Program Planning in Allied HealthSurrey M Walton, Kibum Kim, Saul J Weiner
Journal of Managed Care Pharmacy : JMCP|January 15, 2004
Cost-effectiveness analysis and the formulary decision-making processZhixiao Wang, J Warren Salmon, Surrey M Walton
Current Medical Research and Opinion|August 10, 2010
Cost analysis of flavocoxid compared to naproxen for management of mild to moderate OASurrey M Walton, Glen T Schumock, David Andrew McLain
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Journal of Medical Systems|June 3, 2004
The pharmacist shortage and medication errors: issues and evidenceSurrey M Walton
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2015
Cost-effectiveness of the 70-gene signature versus adjuvant! Online and systematic chemotherapy for risk stratification of patients with node-negative breast cancer: does accuracy matter?Catherine Rahilly-Tierney, Surrey M Walton
Healthcare Financial Management : Journal of the Healthcare Financial Management Association|October 17, 2003
Expenditures for prescription drugs: too much or not enough?Glen T Schumock, Surrey M Walton
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2005
Discussion of "Comparison of clinical and cost-effectiveness of 3 intervention strategies for HIV wasting"Hind T Hatoum, Surrey M Walton
Pharmacy (Basel, Switzerland)|July 5, 2018
Is It a Good Time to Be a Pharmacist in the US?Surrey M Walton, Henri R Manasse
Pharmacoeconomics|October 2, 2014
Should off-label drugs be included as comparators in pharmacoeconomic studies?Surrey M Walton, Glen T Schumock
Vaccine|February 20, 2016
HPV vaccine: Less is moreRachel Caskey, Steven Andes, Surrey M Walton
Journal of Allied Health|September 11, 2017
Considering Recent Trends in Healthcare Labor Markets in Educational Program Planning in Allied HealthSurrey M Walton, Kibum Kim, Saul J Weiner
Journal of Managed Care Pharmacy : JMCP|January 15, 2004
Cost-effectiveness analysis and the formulary decision-making processZhixiao Wang, J Warren Salmon, Surrey M Walton
Current Medical Research and Opinion|August 10, 2010
Cost analysis of flavocoxid compared to naproxen for management of mild to moderate OASurrey M Walton, Glen T Schumock, David Andrew McLain
Pageof 9